CareFirst moves for class certification in US case against J&J over Stelara
MLex Summary: CareFirst asked a US federal judge to certify two proposed classes of third-party payers in a case accusing Johnson & Johnson of unlawfully delaying the introduction of biosimilar competition...To view the full article, register now.
Already a subscriber? Click here to view full article